Easy, drive the sp down 0.1c and let the money run out. CHM gets declared insolvent and will be delisted. Sh end up with nothing. But as CHM has no debts or creditors demands, the board agrees sell the company to the highest bidder, Paul Hopper for $1. After the dust settled Hopper sells CHM for $500m-1b, pays the former board a nice bonus and that's it.
Centro Group is the best example, after all debts were paid by the banks who took over for $1. We sh ended up with nothing, just got a few bucks back via a class action.The group later was sold for $billions of profit. Hopper learns from the best which is not the best for SH.
He claims he can't raise higher when others can. At RAD the CEO took matters in his own hand and came back with Lantheus and truckloads of money. Where is a will, there is a way. Unfortunately CHM's CEO's effort to secure donation at AUD 5.6m got underminded twice by Hooper's 50%, partially taken up raises. And IMU's CEO hasn't got the guts to stand up against him.
This is a devil's attempt to drive a sp down and not a chaiman's aim to work for the comp and SH.
If I am wrong, how else can it be explained that each raise, despite clinical progress is done constantly lower at increasing discounts, which is contrarily to a bio-tech textbook.
IMU Price at posting:
2.2¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)